🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › Massachusetts › Boston

Urothelial (Transitional Cell) Carcinoma clinical trials in Boston, MA

11 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #7, Boston
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

RecruitingPhase 1
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07090499

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RecruitingObservational study
  • Mass General Brigham, Boston
  • Brigham and Women's Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

RecruitingPhase 1/2
  • Tufts Medical Center, Boston
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

RecruitingPhase 1
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06966024

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

RecruitingPhase 3
  • Research Site, Boston
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07720284

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT06451497

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

RecruitingObservational study
  • Dana-Farber Cancer Institute, Boston
Ages 65 and older · All sexes · Updated Feb 17, 2026 · NCT06138561

Sacituzumab Govitecan Plus EV in Metastatic UC

RecruitingPhase 1/2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT04724018

Urothelial (Transitional Cell) Carcinoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.